Commission Implementing Regulation (EU) 2019/238 of 8 February 2019 amending Regulation (EU) No 37/2010 to classify the substance ovotransferrin as regards its maximum residue limit
Proposed act with possible EEA relevance
Adopted act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
Draft Joint Committee Decision (JCD) under consideration by the EU (EEAS) and the EFTA States (Iceland, Liechtenstein and Norway) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Legal documents
Commission Implementing Regulation (EU) 2019/238 of 8 February 2019 amending Regulation (EU) No 37/2010 to classify the substance ovotransferrin as regards its maximum residue limit
Durchführungsverordnung (EU) 2019/238 der Kommission vom 8. Februar 2019 zur Änderung der Verordnung (EU) Nr. 37/2010 in Bezug auf die Einstufung des Stoffs Ovotransferrin hinsichtlich der Rückstandshöchstmenge
History
13.06.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
08.02.2019
Adoption date in the EU
03.03.2019
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.